Shelley Johnson Mba

Shelley Johnson, MBA, PMP has extensive experience in the pharmaceutical industry with a focus on clinical operations. Shelley is currently the Executive Director of Registry Operations at PTC Therapeutics, Inc. Prior to this, they served as the Head of Clinical Operations at Prolong Pharmaceuticals and the Director, Head of Clinical Operations at InfaCare Pharmaceuticals. Shelley has also held positions at Turing Pharmaceuticals AG as the Director of Clinical Trial Management, Shire Pharmaceuticals as the Associate Director of Global Clinical Operations Lead, Novotech as the Director of US Operations, Schering-Plough Research Institute as the CRA Manager, Pfizer Pharmaceuticals as a Senior Clinical Program Manager, and Agouron Pharmaceuticals as a Clinical Research Scientist. Shelley consistently demonstrated their expertise and leadership in various roles throughout their career.

Shelley Johnson, MBA, PMP has an extensive educational background in business administration and management. Shelley obtained their DBA degree in Business Administration, Management and Operations from the University of Phoenix, which they pursued from 2009 to 2015. Prior to that, Shelley completed their MBA in Business Administration and Management, General from the same institution.

Alongside their educational accomplishments, Shelley has also acquired additional certifications to enhance their professional skills. Shelley obtained the certification "Using Questions to Foster Critical Thinking and Curiosity" from LinkedIn in September 2018. Additionally, they have obtained the Project Management Professional (PMP) certification from the Project Management Institute, although the exact date of acquisition is unknown.

Based on the provided information, it can be concluded that Shelley Johnson is a well-educated individual with a focus on business administration and management, possessing a DBA degree, MBA degree, and certifications in critical thinking and project management.